HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
190822.0,241826,2180-06-16 07:29:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2180-6-15**] 11:15 AM
 URINE CULTURE - At [**2180-6-15**] 11:53 AM
 URINE CULTURE - At [**2180-6-15**] 02:00 PM
 NASAL SWAB - At [**2180-6-15**] 02:00 PM
 BLOOD CULTURED - At [**2180-6-15**] 02:10 PM
 EEG - At [**2180-6-15**] 05:50 PM
 INDWELLING PORT (PORTACATH) - START [**2180-6-15**] 06:16 PM
 MAGNETIC RESONANCE IMAGING - At [**2180-6-15**] 10:30 PM
 FEVER - 101.8
F - [**2180-6-15**] 12:00 PM
   ..
   -MRI: pending read
   -had n/v during MRI, ?aspiration, CXR: improved from AM
   -worsening nausea, KUB: nl, treated with zofran/compazine prn with
   effect
   -ABG all normal values
   -started methylene blue for [**Year (4 digits) **] toxicity
   -repleted K in AM
   Allergies:
   Demerol (Oral) (Meperidine Hcl)
   Nausea/Vomiting
   Last dose of Antibiotics:
   Vancomycin - [**2180-6-15**] 08:18 PM
   Piperacillin - [**2180-6-15**] 11:53 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2180-6-15**] 07:41 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2180-6-16**] 07:19 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.8
C (101.8
   Tcurrent: 36.7
C (98
   HR: 105 (82 - 125) bpm
   BP: 152/77(97) {105/56(71) - 169/88(165)} mmHg
   RR: 19 (8 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 73.6 kg (admission): 72.8 kg
             Total In:
                                                                  1,841 mL
                                                                    303 mL
   PO:
             TF:
   IVF:
                                                                  1,841 mL
                                                                    303 mL
   Blood products:
   Total out:
                                                                  2,480 mL
                                                                    910 mL
   Urine:
                                                                  2,180 mL
                                                                    860 mL
   NG:
                                                                    300 mL
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                   -639 mL
                                                                   -607 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: 7.38/35/91.[**Numeric Identifier 253**]/18/-3
   Physical Examination
   HEENT: PERRL, sclera anicteric, dry MM, oropharynx clear,
   CV: mildly tachy, normal S1 and S2, no m/r/g
   PULM: CTAB, no w/r appreciated
   ABD: +BS, soft, non-tender, non-distended with no palpable masses.
   LIMBS: cool, 2+ radial and DP pulses, no edema.
   SKIN: Dry skin on legs, no rashes.
   NEURO: oriented to person only, pupils reactive, moving all extremities
   and intermittently follows commands
   Labs / Radiology
   147 K/uL
   8.1 g/dL
   106 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.1 mEq/L
   24 mg/dL
   114 mEq/L
   142 mEq/L
   24.5 %
   6.2 K/uL
         [image002.jpg]
                             [**2180-6-15**]  11:41 AM
                             [**2180-6-15**]  07:47 PM
                             [**2180-6-16**]  03:56 AM
   WBC
   6.2
   Hct
   24.5
   Plt
   147
   Cr
   0.9
   TCO2
   19
   22
   Glucose
   106
   Other labs: PT / PTT / INR:12.3/24.2/1.0, ALT / AST:46/38, Alk Phos / T
   Bili:72/0.5, Lactic Acid:1.1 mmol/L, Ca++:7.5 mg/dL, Mg++:2.1 mg/dL,
   PO4:2.8 mg/dL
   .
   .
   BCx/Ucx pending
   .
   CXR: yesterday
   .
   MRI - pend
   Assessment and Plan
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 NAUSEA / VOMITING
   .
   Assessment and Plan
   74-year-old woman with recurrent follicular cell lymphoma who presented
   for induction with protocol Ofatumumab/ICE and was transferred to the
   ICU for acute mental status changes and fever.
   .
   # Acute MS changes: Etiology unclear, though concerning for [**Name (NI) 8017**]
   toxicity given recent completion of chemo regimen with known
   neurotoxicity. Infection also likely contributing with fever,
   tachycardia and tachypnea.  CXR with possible RLL infiltrate.  Hepatic
   encephalopathy unlikely given only mild elevation to LFTs. This is very
   unlikely to be meningitis acquired since admission to hospital, will
   hold off on LP for now and d/w neuro.
   - cont methylene blue for poss [**Name (NI) 8017**] toxicity.
   - strict aspiration precautions
   - f/u neuro recs
   - cont empiric Vanc/Zosyn
   - f/u MRI
   - f/u blood & urine cx
   - consider EEG
   .
   # RLL infiltrate: Pt with MS changes, witnessed emesis and likely
   aspiration event.  Currently tachypneic and febrile though oxygenating
   well, CXR concerning for RLL infiltrate awaiting final read. Pt just
   completed a course of chemo and WBC trending down.  Pt is now hosp day
   3 and will need to cover hosp acq organisms.  Lactate normal on initial
   gas
   - start empiric Vanc/Zosyn
   - strict aspiration precautions
   - monitor resp status serially
   - serial ABGs/lactates
   .
   # Nausea: KUB nl, likely [**12-20**] to [**Month/Day (2) **] toxicity
   - zofran prn / compazine prn
   .
   # Follicular Cell Lymphoma: Pt with recurrent disease after initial
   treatment with RCHOP, she was admitted for induction with ICE+study
   [**Doctor Last Name **] in protocol regimen.  Pt was tolerating regimen well until today
   when she developped acute MS changes.  Now concern for [**Doctor Last Name 8017**]
   neurotoxicity, methylene blue indicated and safe at 6GPD levels NL.
   - chemo regimen complete, continue aggressive hydration
   - start methylene blue 50mg q6hr for [**Doctor Last Name 8017**] neurotoxicity
   - f/u BMT recs
   .
   # Transaminitis: Patient has a mild transaminitis and elevated LDH
   likely due to chemo regimen and lysis of lymphoma cells.  MS changes
   unlikely due to hepatic encephalopathy but will check ammonia
   - continue to trend LFTs
   - f/u ammonia level
   .
   # FEN: NPO with NS IVF at 100cc/hr
   - replete electrolytes prn
   .
   # PPx: pneumoboots, famotidine IV
   .
   # Comm: With patient and Son [**Name (NI) 225**] at [**Telephone/Fax (1) 8018**]
   - needs ICU consent
   .
   # Access: right upper chest port and PIV,
   - will get 2^nd PIV
   .
   # Code: FULL CODE (confirmed with patient)
   .
   # Dispo: pending above
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Indwelling Port (PortaCath) - [**2180-6-15**] 06:16 PM
   20 Gauge - [**2180-6-16**] 06:41 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2180-6-15**] 11:15 AM
 URINE CULTURE - At [**2180-6-15**] 11:53 AM
 URINE CULTURE - At [**2180-6-15**] 02:00 PM
 NASAL SWAB - At [**2180-6-15**] 02:00 PM
 BLOOD CULTURED - At [**2180-6-15**] 02:10 PM
 EEG - At [**2180-6-15**] 05:50 PM
 INDWELLING PORT (PORTACATH) - START [**2180-6-15**] 06:16 PM
 MAGNETIC RESONANCE IMAGING - At [**2180-6-15**] 10:30 PM
 FEVER - 101.8
F - [**2180-6-15**] 12:00 PM
   ..
   -MRI: pending read
   -had n/v during MRI, ?aspiration, CXR: improved from AM
   -worsening nausea, KUB: nl, treated with zofran/compazine prn with
   effect
   -ABG all normal values
   -started methylene blue for [**Year (4 digits) **] toxicity
   -repleted K in AM
   Allergies:
   Demerol (Oral) (Meperidine Hcl)
   Nausea/Vomiting
   Last dose of Antibiotics:
   Vancomycin - [**2180-6-15**] 08:18 PM
   Piperacillin - [**2180-6-15**] 11:53 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2180-6-15**] 07:41 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2180-6-16**] 07:19 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.8
C (101.8
   Tcurrent: 36.7
C (98
   HR: 105 (82 - 125) bpm
   BP: 152/77(97) {105/56(71) - 169/88(165)} mmHg
   RR: 19 (8 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 73.6 kg (admission): 72.8 kg
             Total In:
                                                                  1,841 mL
                                                                    303 mL
   PO:
             TF:
   IVF:
                                                                  1,841 mL
                                                                    303 mL
   Blood products:
   Total out:
                                                                  2,480 mL
                                                                    910 mL
   Urine:
                                                                  2,180 mL
                                                                    860 mL
   NG:
                                                                    300 mL
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                   -639 mL
                                                                   -607 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: 7.38/35/91.[**Numeric Identifier 253**]/18/-3
   Physical Examination
   HEENT: PERRL, sclera anicteric, dry MM, oropharynx clear,
   CV: mildly tachy, normal S1 and S2, no m/r/g
   PULM: CTAB, no w/r appreciated
   ABD: +BS, soft, non-tender, non-distended with no palpable masses.
   LIMBS: cool, 2+ radial and DP pulses, no edema.
   SKIN: Dry skin on legs, no rashes.
   NEURO: oriented to person only, pupils reactive, moving all extremities
   and intermittently follows commands
   Labs / Radiology
   147 K/uL
   8.1 g/dL
   106 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.1 mEq/L
   24 mg/dL
   114 mEq/L
   142 mEq/L
   24.5 %
   6.2 K/uL
         [image002.jpg]
                             [**2180-6-15**]  11:41 AM
                             [**2180-6-15**]  07:47 PM
                             [**2180-6-16**]  03:56 AM
   WBC
   6.2
   Hct
   24.5
   Plt
   147
   Cr
   0.9
   TCO2
   19
   22
   Glucose
   106
   Other labs: PT / PTT / INR:12.3/24.2/1.0, ALT / AST:46/38, Alk Phos / T
   Bili:72/0.5, Lactic Acid:1.1 mmol/L, Ca++:7.5 mg/dL, Mg++:2.1 mg/dL,
   PO4:2.8 mg/dL
   .
   .
   BCx/Ucx pending
   .
   CXR: yesterday
   .
   MRI - pend
   Assessment and Plan
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 NAUSEA / VOMITING
   .
   Assessment and Plan
   74-year-old woman with recurrent follicular cell lymphoma who presented
   for induction with protocol Ofatumumab/ICE and was transferred to the
   ICU for acute mental status changes and fever.
   .
   # Acute MS changes: Etiology unclear, though concerning for [**Name (NI) 8017**]
   toxicity given recent completion of chemo regimen with known
   neurotoxicity. Infection also likely contributing with fever,
   tachycardia and tachypnea.  CXR with possible RLL infiltrate.  Hepatic
   encephalopathy unlikely given only mild elevation to LFTs. This is very
   unlikely to be meningitis acquired since admission to hospital, will
   hold off on LP for now and d/w neuro.
   - cont methylene blue for poss [**Name (NI) 8017**] toxicity.
   - strict aspiration precautions
   - f/u neuro recs
   - cont empiric Vanc/Zosyn
   - f/u MRI
   - f/u blood & urine cx
   - consider EEG
   .
   # RLL infiltrate: Pt with MS changes, witnessed emesis and likely
   aspiration event.  Currently tachypneic and febrile though oxygenating
   well, CXR concerning for RLL infiltrate awaiting final read. Pt just
   completed a course of chemo and WBC trending down.  Pt is now hosp day
   3 and will need to cover hosp acq organisms.  Lactate normal on initial
   gas
   - start empiric Vanc/Zosyn
   - strict aspiration precautions
   - monitor resp status serially
   - serial ABGs/lactates
   .
   # Nausea: KUB nl, likely [**12-20**] to [**Month/Day (2) **] toxicity
   - zofran prn / compazine prn
   .
   # Follicular Cell Lymphoma: Pt with recurrent disease after initial
   treatment with RCHOP, she was admitted for induction with ICE+study
   [**Doctor Last Name **] in protocol regimen.  Pt was tolerating regimen well until today
   when she developped acute MS changes.  Now concern for [**Doctor Last Name 8017**]
   neurotoxicity, methylene blue indicated and safe at 6GPD levels NL.
   - chemo regimen complete, continue aggressive hydration
   - start methylene blue 50mg q6hr for [**Doctor Last Name 8017**] neurotoxicity
   - f/u BMT recs
   .
   # Transaminitis: Patient has a mild transaminitis and elevated LDH
   likely due to chemo regimen and lysis of lymphoma cells.  MS changes
   unlikely due to hepatic encephalopathy but will check ammonia
   - continue to trend LFTs
   - f/u ammonia level
   .
   # FEN: NPO with NS IVF at 100cc/hr
   - replete electrolytes prn
   .
   # PPx: pneumoboots, famotidine IV
   .
   # Comm: With patient and Son [**Name (NI) 225**] at [**Telephone/Fax (1) 8018**]
   - needs ICU consent
   .
   # Access: right upper chest port and PIV,
   - will get 2^nd PIV
   .
   # Code: FULL CODE (confirmed with patient)
   .
   # Dispo: pending above
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Indwelling Port (PortaCath) - [**2180-6-15**] 06:16 PM
   20 Gauge - [**2180-6-16**] 06:41 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, the patient is a 74-year-old woman with recurrent follicular cell lymphoma who presented for induction with protocol Ofatumumab/ICE and was transferred to the ICU for acute mental status changes and fever.

The patient has the following conditions:

1. Altered mental status (not delirium), which is likely due to [**Name (NI) 8017**] toxicity, infection, or other factors.
2. Nausea and vomiting, which may be related to chemotherapy, infection, or other causes.
3. Fever, which may be related to infection or other factors.
4. Respiratory support with nasal cannula and SpO2 of 97%.
5. Abnormal laboratory results, including elevated liver enzymes, lactate, and LDH, which may be related to chemotherapy or other causes.

The patient has undergone the following treatments:

1. Methylene blue for possible [**Name (NI) 8017**] toxicity.
2. Strict aspiration precautions.
3. Empiric vancomycin and zosyn for possible infection.
4. Chemotherapy regimen complete, with plans to continue aggressive hydration and monitor for [**Doctor Last Name 8017**] neurotoxicity.
5. Folic acid supplementation.

The patient has the following medical history:

1. Recurrent follicular cell lymphoma.
2. Recent completion of chemotherapy regimen with Ofatumumab/ICE.

The patient's vital signs are as follows:

1. Temperature: 101.8°F (38.8°C).
2. Heart rate: 105 beats per minute (bpm).
3. Blood pressure: 152/77 mmHg.
4. Respiratory rate: 19 breaths per minute (bpm).
5. SpO2: 97%.

The patient's physical examination is as follows:

1. HEENT: PERRL, sclera anicteric, dry MM, oropharynx clear.
2. CV: mildly tachycardic, normal S1 and S2, no murmurs or gallop.
3. PULM: CTAB, no wheezing or rhonchi appreciated.
4. ABD: soft, non-tender, non-distended, with no palpable masses.
5. LIMBS: cool, 2+ radial and DP pulses, no edema.
6. SKIN: dry skin on legs, no rashes.
7. NEURO: oriented to person only, pupils reactive, moving all extremities and intermittently follows commands.

The patient's laboratory results are as follows:

1. WBC: 6.2 K/uL.
2. Hct: 24.5%.
3. Plt: 147 K/uL.
4. Cr: 0.9 mg/dL.
5. TCO2: 19 mmHg.
6. Glucose: 106 mg/dL.
7. Lactic acid: 1.1 mmol/L.
8. Ca++: 7.5 mg/dL.
9. Mg++: 2.1 mg/dL.
10. PO4: 2.8 mg/dL.

The patient's potential medical complications include:

1. Sepsis or septic shock due to infection.
2. Respiratory failure due to pneumonia or other causes.
3. Neurological complications due to [**Name (NI) 8017**] toxicity or other causes.
4. Hepatic encephalopathy due to liver failure.
5. Renal failure due to acute kidney injury.

The patient's potential medical interventions include:

1. Administration of antibiotics for possible infection.
2. Administration of antiviral medications for possible viral infection.
3. Administration of antifungal medications for possible fungal infection.
4. Administration of corticosteroids for possible inflammation or edema.
5. Administration of vasopressors for possible hypotension.
6. Administration of diuretics for possible fluid overload.
7. Administration of electrolyte supplements for possible electrolyte imbalances.
8. Administration of blood products for possible bleeding or anemia.
9. Administration of medications for possible nausea and vomiting.
10. Administration of medications for possible pain or discomfort."
190822.0,241826,2180-06-16 07:29:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2180-6-15**] 11:15 AM
 URINE CULTURE - At [**2180-6-15**] 11:53 AM
 URINE CULTURE - At [**2180-6-15**] 02:00 PM
 NASAL SWAB - At [**2180-6-15**] 02:00 PM
 BLOOD CULTURED - At [**2180-6-15**] 02:10 PM
 EEG - At [**2180-6-15**] 05:50 PM
 INDWELLING PORT (PORTACATH) - START [**2180-6-15**] 06:16 PM
 MAGNETIC RESONANCE IMAGING - At [**2180-6-15**] 10:30 PM
 [**Year (4 digits) **] - 101.8
F - [**2180-6-15**] 12:00 PM
   ..
   -MRI: pending read
   -had n/v during MRI, ?aspiration, CXR: improved from AM
   -worsening nausea, KUB: nl, treated with zofran/compazine prn with
   effect
   -ABG all normal values
   -started methylene blue for [**Year (4 digits) **] toxicity
   -repleted K in AM
   Allergies:
   Demerol (Oral) (Meperidine Hcl)
   Nausea/Vomiting
   Last dose of Antibiotics:
   Vancomycin - [**2180-6-15**] 08:18 PM
   Piperacillin - [**2180-6-15**] 11:53 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2180-6-15**] 07:41 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2180-6-16**] 07:19 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.8
C (101.8
   Tcurrent: 36.7
C (98
   HR: 105 (82 - 125) bpm
   BP: 152/77(97) {105/56(71) - 169/88(165)} mmHg
   RR: 19 (8 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 73.6 kg (admission): 72.8 kg
             Total In:
                                                                  1,841 mL
                                                                    303 mL
   PO:
             TF:
   IVF:
                                                                  1,841 mL
                                                                    303 mL
   Blood products:
   Total out:
                                                                  2,480 mL
                                                                    910 mL
   Urine:
                                                                  2,180 mL
                                                                    860 mL
   NG:
                                                                    300 mL
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                   -639 mL
                                                                   -607 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula, 2L
   SpO2: 97%
   ABG: 7.38/35/91.[**Numeric Identifier 253**]/18/-3
   Physical Examination
   HEENT: PERRL, sclera anicteric, dry MM, oropharynx clear,
   CV: mildly tachy, normal S1 and S2, no m/r/g
   PULM: CTAB, no w/r appreciated
   ABD: +BS, soft, non-tender, non-distended with no palpable masses.
   LIMBS: cool, 2+ radial and DP pulses, no edema.
   SKIN: Dry skin on legs, no rashes.
   NEURO: oriented to person only, pupils reactive, moving all extremities
   and intermittently follows commands
   Labs / Radiology
   147 K/uL
   8.1 g/dL
   106 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.1 mEq/L
   24 mg/dL
   114 mEq/L
   142 mEq/L
   24.5 %
   6.2 K/uL
        [image002.jpg]
                             [**2180-6-15**]  11:41 AM
                             [**2180-6-15**]  07:47 PM
                             [**2180-6-16**]  03:56 AM
   WBC
   6.2
   Hct
   24.5
   Plt
   147
   Cr
   0.9
   TCO2
   19
   22
   Glucose
   106
   Other labs: PT / PTT / INR:12.3/24.2/1.0, ALT / AST:46/38, Alk Phos / T
   Bili:72/0.5, Lactic Acid:1.1 mmol/L, Ca++:7.5 mg/dL, Mg++:2.1 mg/dL,
   PO4:2.8 mg/dL
   .
   .
   BCx/Ucx pending
   .
   CXR: yesterday
   .
   MRI - pend
   Assessment and Plan
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 NAUSEA / VOMITING
   .
   Assessment and Plan
   74-year-old woman with recurrent follicular cell lymphoma who presented
   for induction with protocol Ofatumumab/ICE and was transferred to the
   ICU for acute mental status changes and [**Year (4 digits) **].
   .
   # Acute MS changes: Etiology unclear, though concerning for [**Name (NI) 8017**]
   toxicity given recent completion of chemo regimen with known
   neurotoxicity. Infection also likely contributing with [**Name (NI) **],
   tachycardia and tachypnea.  CXR with possible RLL infiltrate.  Hepatic
   encephalopathy unlikely given only mild elevation to LFTs. This is very
   unlikely to be meningitis acquired since admission to hospital, will
   hold off on LP for now and d/w neuro.
   - cont methylene blue and thiamine for [**Name (NI) 8017**] toxicity.
   - strict aspiration precautions
   - f/u neuro recs
   - cont empiric Vanc/Zosyn
   - f/u MRI
   - f/u blood & urine cx
   - f/u EEG
   .
   # ID: Pt with MS changes, witnessed emesis and likely aspiration
   event.  Currently tachypneic and febrile though oxygenating well, CXR
   concerning for RLL infiltrate although on f/u CXR today appears to be
   resolved. Pt just completed a course of chemo and WBC trending down.
   Pt is now hosp day 3 and will need to cover hosp acq organisms.
   Lactate normal on initial gas. Arrived in [**Hospital Unit Name 4**] yesterday with T 101.8,
   since then has been afebrile.
   - cont empiric Vanc/Zosyn for 48 hrs if neg cultures/afebrile
   - strict aspiration precautions
   - monitor resp status serially
   - ABGs/lactates prn
   .
   # Nausea: KUB nl, likely [**12-20**] to [**Month/Day (2) **] toxicity
   - zofran prn / compazine prn
   - if worsens will place NGT
   .
   # Non gap acidosis: likely secondary to NS fluid resuscitation
   - will continue to trend on AM lytes
   .
   # Follicular Cell Lymphoma: Pt with recurrent disease after initial
   treatment with RCHOP, she was admitted for induction with ICE+study
   [**Doctor Last Name **] in protocol regimen.  Pt was tolerating regimen well until today
   when she developped acute MS changes.  Now concern for [**Doctor Last Name 8017**]
   neurotoxicity, methylene blue indicated and safe at 6GPD levels NL.
   - chemo regimen complete, continue aggressive hydration
   - start methylene blue 50mg q6hr for [**Doctor Last Name 8017**] neurotoxicity
   - f/u BMT recs
   .
   # Transaminitis: Patient has a mild transaminitis and elevated LDH
   likely due to chemo regimen and lysis of lymphoma cells.  MS changes
   unlikely due to hepatic encephalopathy but will check ammonia
   - continue to trend LFTs
   - f/u ammonia level
   .
   # FEN: NPO with LR at 100cc/hr
   - replete electrolytes prn
   .
   # PPx: pneumoboots, famotidine IV
   .
   # Comm: With patient and Son [**Name (NI) 225**] at [**Telephone/Fax (1) 8018**]
   - needs ICU consent
   .
   # Access: right upper chest port and PIV,
   - will get 2^nd PIV
   .
   # Code: FULL CODE (confirmed with patient)
   .
   # Dispo: pending above
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Indwelling Port (PortaCath) - [**2180-6-15**] 06:16 PM
   20 Gauge - [**2180-6-16**] 06:41 AM x2
   Prophylaxis:
   DVT:
   Stress ulcer: famotidine
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU for methylene blue treatment
   ------ Protected Section ------
   MICU ATTENDING PROGRESS NOTE
   I saw and examined the patient and was physically present with the ICU
   team for the key portions of the services provided. I agree with the
   resident note, including the assessment and plan. I would emphasize and
   add the following points: 74 yo F h/o recurrent follicular cell
   lymphoma admitted 3 days ago for induction chemotherapy
   (Ofatumumab/ICE, per phase II study).   Transferred to [**Hospital Unit Name 4**] for further
   management of acutely altered MS [**First Name (Titles) **] [**Last Name (Titles) **] concerning for infection
   (asp pna), drug reaction, or possible CSF event.
   Exam notable for Tm 101.8-->98  HR 105  BP 150/70  20's  97% 2L NC
   Somnolent but more arousable this morning, intermittenly follows
   commands, answers questions, PERRLA, CTA X d b/b BS, tachy rr s1s2,
   soft +BS, moves all 4, no obvious focal deficit w/ limited cooperation
   with exam
   Labs reviewed:    wbc 6.2, plt 147, hct 24.5, cr 0.9, ag 10, inr 1.0,
   lfts stable
   Bl/urine cx's pending w/ ngtd
   CXR RML infiltrate appears much less pronounced
   Acute MS change is very concerning for [**Last Name (Titles) 8017**] toxicity vs acute CNS
   process or sz.  Her recent [**Last Name (Titles) **] is concerning for infection and given
   her CXR findings and history of emesis, we are treating for
   HAP/aspiration pna.  Agree with plan to continue broad antibx for
   hospital acquired infection and aspiration pna (zosyn, vanco), tapering
   pending cx results. She is getting methylene blue for ? [**Last Name (Titles) 8017**] toxicity.
   Will F/u eeg and MRI results, and additional neurology recs.  She
   remains NPO with aspiration precautions, monitoring for signs of
   hypoventilation or inability to protect airway/secretions. We continue
   maintenance fluids while NPO, using LR given her NAGMA which is most
   likely [**12-20**] fluids given with her chemo. Continue compazine for
   nausea--and consider NGT placement if emesis recurs. Follow cbc as
   counts will likely nadir in the next few days post chemo. ICU: Boots,
   H2B, port, 2PIVs.  Remainder of plan as outlined in resident note.
   Patient is critically ill
   Total time: 50 min
   ------ Protected Section Addendum Entered By:[**Name (NI) 143**] [**Last Name (NamePattern1) 144**], MD
   on:[**2180-6-16**] 04:08 PM ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2180-6-15**] 11:15 AM
 URINE CULTURE - At [**2180-6-15**] 11:53 AM
 URINE CULTURE - At [**2180-6-15**] 02:00 PM
 NASAL SWAB - At [**2180-6-15**] 02:00 PM
 BLOOD CULTURED - At [**2180-6-15**] 02:10 PM
 EEG - At [**2180-6-15**] 05:50 PM
 INDWELLING PORT (PORTACATH) - START [**2180-6-15**] 06:16 PM
 MAGNETIC RESONANCE IMAGING - At [**2180-6-15**] 10:30 PM
 [**Year (4 digits) **] - 101.8
F - [**2180-6-15**] 12:00 PM
   ..
   -MRI: pending read
   -had n/v during MRI, ?aspiration, CXR: improved from AM
   -worsening nausea, KUB: nl, treated with zofran/compazine prn with
   effect
   -ABG all normal values
   -started methylene blue for [**Year (4 digits) **] toxicity
   -repleted K in AM
   Allergies:
   Demerol (Oral) (Meperidine Hcl)
   Nausea/Vomiting
   Last dose of Antibiotics:
   Vancomycin - [**2180-6-15**] 08:18 PM
   Piperacillin - [**2180-6-15**] 11:53 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2180-6-15**] 07:41 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2180-6-16**] 07:19 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.8
C (101.8
   Tcurrent: 36.7
C (98
   HR: 105 (82 - 125) bpm
   BP: 152/77(97) {105/56(71) - 169/88(165)} mmHg
   RR: 19 (8 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 73.6 kg (admission): 72.8 kg
             Total In:
                                                                  1,841 mL
                                                                    303 mL
   PO:
             TF:
   IVF:
                                                                  1,841 mL
                                                                    303 mL
   Blood products:
   Total out:
                                                                  2,480 mL
                                                                    910 mL
   Urine:
                                                                  2,180 mL
                                                                    860 mL
   NG:
                                                                    300 mL
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                   -639 mL
                                                                   -607 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula, 2L
   SpO2: 97%
   ABG: 7.38/35/91.[**Numeric Identifier 253**]/18/-3
   Physical Examination
   HEENT: PERRL, sclera anicteric, dry MM, oropharynx clear,
   CV: mildly tachy, normal S1 and S2, no m/r/g
   PULM: CTAB, no w/r appreciated
   ABD: +BS, soft, non-tender, non-distended with no palpable masses.
   LIMBS: cool, 2+ radial and DP pulses, no edema.
   SKIN: Dry skin on legs, no rashes.
   NEURO: oriented to person only, pupils reactive, moving all extremities
   and intermittently follows commands
   Labs / Radiology
   147 K/uL
   8.1 g/dL
   106 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.1 mEq/L
   24 mg/dL
   114 mEq/L
   142 mEq/L
   24.5 %
   6.2 K/uL
        [image002.jpg]
                             [**2180-6-15**]  11:41 AM
                             [**2180-6-15**]  07:47 PM
                             [**2180-6-16**]  03:56 AM
   WBC
   6.2
   Hct
   24.5
   Plt
   147
   Cr
   0.9
   TCO2
   19
   22
   Glucose
   106
   Other labs: PT / PTT / INR:12.3/24.2/1.0, ALT / AST:46/38, Alk Phos / T
   Bili:72/0.5, Lactic Acid:1.1 mmol/L, Ca++:7.5 mg/dL, Mg++:2.1 mg/dL,
   PO4:2.8 mg/dL
   .
   .
   BCx/Ucx pending
   .
   CXR: yesterday
   .
   MRI - pend
   Assessment and Plan
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 NAUSEA / VOMITING
   .
   Assessment and Plan
   74-year-old woman with recurrent follicular cell lymphoma who presented
   for induction with protocol Ofatumumab/ICE and was transferred to the
   ICU for acute mental status changes and [**Year (4 digits) **].
   .
   # Acute MS changes: Etiology unclear, though concerning for [**Name (NI) 8017**]
   toxicity given recent completion of chemo regimen with known
   neurotoxicity. Infection also likely contributing with [**Name (NI) **],
   tachycardia and tachypnea.  CXR with possible RLL infiltrate.  Hepatic
   encephalopathy unlikely given only mild elevation to LFTs. This is very
   unlikely to be meningitis acquired since admission to hospital, will
   hold off on LP for now and d/w neuro.
   - cont methylene blue and thiamine for [**Name (NI) 8017**] toxicity.
   - strict aspiration precautions
   - f/u neuro recs
   - cont empiric Vanc/Zosyn
   - f/u MRI
   - f/u blood & urine cx
   - f/u EEG
   .
   # ID: Pt with MS changes, witnessed emesis and likely aspiration
   event.  Currently tachypneic and febrile though oxygenating well, CXR
   concerning for RLL infiltrate although on f/u CXR today appears to be
   resolved. Pt just completed a course of chemo and WBC trending down.
   Pt is now hosp day 3 and will need to cover hosp acq organisms.
   Lactate normal on initial gas. Arrived in [**Hospital Unit Name 4**] yesterday with T 101.8,
   since then has been afebrile.
   - cont empiric Vanc/Zosyn for 48 hrs if neg cultures/afebrile
   - strict aspiration precautions
   - monitor resp status serially
   - ABGs/lactates prn
   .
   # Nausea: KUB nl, likely [**12-20**] to [**Month/Day (2) **] toxicity
   - zofran prn / compazine prn
   - if worsens will place NGT
   .
   # Non gap acidosis: likely secondary to NS fluid resuscitation
   - will continue to trend on AM lytes
   .
   # Follicular Cell Lymphoma: Pt with recurrent disease after initial
   treatment with RCHOP, she was admitted for induction with ICE+study
   [**Doctor Last Name **] in protocol regimen.  Pt was tolerating regimen well until today
   when she developped acute MS changes.  Now concern for [**Doctor Last Name 8017**]
   neurotoxicity, methylene blue indicated and safe at 6GPD levels NL.
   - chemo regimen complete, continue aggressive hydration
   - start methylene blue 50mg q6hr for [**Doctor Last Name 8017**] neurotoxicity
   - f/u BMT recs
   .
   # Transaminitis: Patient has a mild transaminitis and elevated LDH
   likely due to chemo regimen and lysis of lymphoma cells.  MS changes
   unlikely due to hepatic encephalopathy but will check ammonia
   - continue to trend LFTs
   - f/u ammonia level
   .
   # FEN: NPO with LR at 100cc/hr
   - replete electrolytes prn
   .
   # PPx: pneumoboots, famotidine IV
   .
   # Comm: With patient and Son [**Name (NI) 225**] at [**Telephone/Fax (1) 8018**]
   - needs ICU consent
   .
   # Access: right upper chest port and PIV,
   - will get 2^nd PIV
   .
   # Code: FULL CODE (confirmed with patient)
   .
   # Dispo: pending above
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Indwelling Port (PortaCath) - [**2180-6-15**] 06:16 PM
   20 Gauge - [**2180-6-16**] 06:41 AM x2
   Prophylaxis:
   DVT:
   Stress ulcer: famotidine
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU for methylene blue treatment
   ------ Protected Section ------
   MICU ATTENDING PROGRESS NOTE
   I saw and examined the patient and was physically present with the ICU
   team for the key portions of the services provided. I agree with the
   resident note, including the assessment and plan. I would emphasize and
   add the following points: 74 yo F h/o recurrent follicular cell
   lymphoma admitted 3 days ago for induction chemotherapy
   (Ofatumumab/ICE, per phase II study).   Transferred to [**Hospital Unit Name 4**] for further
   management of acutely altered MS [**First Name (Titles) **] [**Last Name (Titles) **] concerning for infection
   (asp pna), drug reaction, or possible CSF event.
   Exam notable for Tm 101.8-->98  HR 105  BP 150/70  20's  97% 2L NC
   Somnolent but more arousable this morning, intermittenly follows
   commands, answers questions, PERRLA, CTA X d b/b BS, tachy rr s1s2,
   soft +BS, moves all 4, no obvious focal deficit w/ limited cooperation
   with exam
   Labs reviewed:    wbc 6.2, plt 147, hct 24.5, cr 0.9, ag 10, inr 1.0,
   lfts stable
   Bl/urine cx's pending w/ ngtd
   CXR RML infiltrate appears much less pronounced
   Acute MS change is very concerning for [**Last Name (Titles) 8017**] toxicity vs acute CNS
   process or sz.  Her recent [**Last Name (Titles) **] is concerning for infection and given
   her CXR findings and history of emesis, we are treating for
   HAP/aspiration pna.  Agree with plan to continue broad antibx for
   hospital acquired infection and aspiration pna (zosyn, vanco), tapering
   pending cx results. She is getting methylene blue for ? [**Last Name (Titles) 8017**] toxicity.
   Will F/u eeg and MRI results, and additional neurology recs.  She
   remains NPO with aspiration precautions, monitoring for signs of
   hypoventilation or inability to protect airway/secretions. We continue
   maintenance fluids while NPO, using LR given her NAGMA which is most
   likely [**12-20**] fluids given with her chemo. Continue compazine for
   nausea--and consider NGT placement if emesis recurs. Follow cbc as
   counts will likely nadir in the next few days post chemo. ICU: Boots,
   H2B, port, 2PIVs.  Remainder of plan as outlined in resident note.
   Patient is critically ill
   Total time: 50 min
   ------ Protected Section Addendum Entered By:[**Name (NI) 143**] [**Last Name (NamePattern1) 144**], MD
   on:[**2180-6-16**] 04:08 PM ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 74-year-old woman with recurrent follicular cell lymphoma who presented to the ICU with acute mental status changes, nausea, and vomiting. She was previously treated with chemotherapy (Ofatumumab/ICE) and was transferred to the ICU for further management. The patient's condition is concerning for infection, drug reaction, or possible central nervous system (CNS) event. She has a history of emesis and a CXR showing a possible right lower lobe infiltrate.

The patient's vital signs are stable, with a temperature of 98°F, heart rate of 105 bpm, and blood pressure of 150/70 mmHg. Her respiratory rate is 20 breaths per minute, and she is oxygenating well with a SpO2 of 97%. Her neurological examination is notable for somnolence, intermittent following of commands, and limited cooperation with examination.

The patient has received antibiotics for hospital-acquired infection and aspiration pneumonia, and is being treated with methylene blue for possible [**Name (NI) 8017**] toxicity. She is NPO with aspiration precautions and is receiving maintenance fluids. Her lactate levels are normal, and her LFTs are stable.

Potential Medical Complications:

1. Infection: The patient is at risk for infection due to her compromised immune system and the presence of a possible right lower lobe infiltrate on her CXR.
2. Drug reaction: The patient is being treated with methylene blue for possible [**Name (NI) 8017**] toxicity, and may be at risk for an adverse reaction to this medication.
3. CNS event: The patient's acute mental status changes may be due to a CNS event such as a seizure, meningitis, or encephalitis.
4. Aspiration pneumonia: The patient's history of emesis and aspiration puts her at risk for aspiration pneumonia.
5. Hepatic encephalopathy: The patient's mild transaminitis and elevated LDH may be indicative of hepatic encephalopathy, although this is unlikely given her stable LFTs.
6. Non-gap acidosis: The patient's non-gap acidosis may be secondary to her recent chemotherapy regimen and fluid resuscitation.
7. Transaminitis: The patient's mild transaminitis may be due to her recent chemotherapy regimen and lysis of lymphoma cells.

Assessment and Plan:

1. Continue broad-spectrum antibiotics for hospital-acquired infection and aspiration pneumonia.
2. Monitor the patient's neurological status closely and consider EEG and MRI to rule out a CNS event.
3. Continue methylene blue for possible [**Name (NI) 8017**] toxicity.
4. Monitor the patient's lactate levels and LFTs closely.
5. Continue maintenance fluids and electrolyte repletion as needed.
6. Consider NGT placement if the patient's nausea and vomiting persist.
7. Follow up with CBC as the patient's counts will likely nadir in the next few days post chemotherapy."
190822.0,241826,2180-06-16 07:29:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2180-6-15**] 11:15 AM
 URINE CULTURE - At [**2180-6-15**] 11:53 AM
 URINE CULTURE - At [**2180-6-15**] 02:00 PM
 NASAL SWAB - At [**2180-6-15**] 02:00 PM
 BLOOD CULTURED - At [**2180-6-15**] 02:10 PM
 EEG - At [**2180-6-15**] 05:50 PM
 INDWELLING PORT (PORTACATH) - START [**2180-6-15**] 06:16 PM
 MAGNETIC RESONANCE IMAGING - At [**2180-6-15**] 10:30 PM
 FEVER - 101.8
F - [**2180-6-15**] 12:00 PM
   ..
   -MRI: pending read
   -had n/v during MRI, ?aspiration, CXR: improved from AM
   -worsening nausea, KUB: nl, treated with zofran/compazine prn with
   effect
   -ABG all normal values
   -started methylene blue for [**Year (4 digits) **] toxicity
   -repleted K in AM
   Allergies:
   Demerol (Oral) (Meperidine Hcl)
   Nausea/Vomiting
   Last dose of Antibiotics:
   Vancomycin - [**2180-6-15**] 08:18 PM
   Piperacillin - [**2180-6-15**] 11:53 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2180-6-15**] 07:41 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2180-6-16**] 07:19 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.8
C (101.8
   Tcurrent: 36.7
C (98
   HR: 105 (82 - 125) bpm
   BP: 152/77(97) {105/56(71) - 169/88(165)} mmHg
   RR: 19 (8 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 73.6 kg (admission): 72.8 kg
             Total In:
                                                                  1,841 mL
                                                                    303 mL
   PO:
             TF:
   IVF:
                                                                  1,841 mL
                                                                    303 mL
   Blood products:
   Total out:
                                                                  2,480 mL
                                                                    910 mL
   Urine:
                                                                  2,180 mL
                                                                    860 mL
   NG:
                                                                    300 mL
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                   -639 mL
                                                                   -607 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula, 2L
   SpO2: 97%
   ABG: 7.38/35/91.[**Numeric Identifier 253**]/18/-3
   Physical Examination
   HEENT: PERRL, sclera anicteric, dry MM, oropharynx clear,
   CV: mildly tachy, normal S1 and S2, no m/r/g
   PULM: CTAB, no w/r appreciated
   ABD: +BS, soft, non-tender, non-distended with no palpable masses.
   LIMBS: cool, 2+ radial and DP pulses, no edema.
   SKIN: Dry skin on legs, no rashes.
   NEURO: oriented to person only, pupils reactive, moving all extremities
   and intermittently follows commands
   Labs / Radiology
   147 K/uL
   8.1 g/dL
   106 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.1 mEq/L
   24 mg/dL
   114 mEq/L
   142 mEq/L
   24.5 %
   6.2 K/uL
        [image002.jpg]
                             [**2180-6-15**]  11:41 AM
                             [**2180-6-15**]  07:47 PM
                             [**2180-6-16**]  03:56 AM
   WBC
   6.2
   Hct
   24.5
   Plt
   147
   Cr
   0.9
   TCO2
   19
   22
   Glucose
   106
   Other labs: PT / PTT / INR:12.3/24.2/1.0, ALT / AST:46/38, Alk Phos / T
   Bili:72/0.5, Lactic Acid:1.1 mmol/L, Ca++:7.5 mg/dL, Mg++:2.1 mg/dL,
   PO4:2.8 mg/dL
   .
   .
   BCx/Ucx pending
   .
   CXR: yesterday
   .
   MRI - pend
   Assessment and Plan
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 NAUSEA / VOMITING
   .
   Assessment and Plan
   74-year-old woman with recurrent follicular cell lymphoma who presented
   for induction with protocol Ofatumumab/ICE and was transferred to the
   ICU for acute mental status changes and fever.
   .
   # Acute MS changes: Etiology unclear, though concerning for [**Name (NI) 8017**]
   toxicity given recent completion of chemo regimen with known
   neurotoxicity. Infection also likely contributing with fever,
   tachycardia and tachypnea.  CXR with possible RLL infiltrate.  Hepatic
   encephalopathy unlikely given only mild elevation to LFTs. This is very
   unlikely to be meningitis acquired since admission to hospital, will
   hold off on LP for now and d/w neuro.
   - cont methylene blue and thiamine for [**Name (NI) 8017**] toxicity.
   - strict aspiration precautions
   - f/u neuro recs
   - cont empiric Vanc/Zosyn
   - f/u MRI
   - f/u blood & urine cx
   - f/u EEG
   .
   # ID: Pt with MS changes, witnessed emesis and likely aspiration
   event.  Currently tachypneic and febrile though oxygenating well, CXR
   concerning for RLL infiltrate although on f/u CXR today appears to be
   resolved. Pt just completed a course of chemo and WBC trending down.
   Pt is now hosp day 3 and will need to cover hosp acq organisms.
   Lactate normal on initial gas. Arrived in [**Hospital Unit Name 4**] yesterday with T 101.8,
   since then has been afebrile.
   - cont empiric Vanc/Zosyn for 48 hrs if neg cultures/afebrile
   - strict aspiration precautions
   - monitor resp status serially
   - ABGs/lactates prn
   .
   # Nausea: KUB nl, likely [**12-20**] to [**Month/Day (2) **] toxicity
   - zofran prn / compazine prn
   - if worsens will place NGT
   .
   # Non gap acidosis: likely secondary to NS fluid resuscitation
   - will continue to trend on AM lytes
   .
   # Follicular Cell Lymphoma: Pt with recurrent disease after initial
   treatment with RCHOP, she was admitted for induction with ICE+study
   [**Doctor Last Name **] in protocol regimen.  Pt was tolerating regimen well until today
   when she developped acute MS changes.  Now concern for [**Doctor Last Name 8017**]
   neurotoxicity, methylene blue indicated and safe at 6GPD levels NL.
   - chemo regimen complete, continue aggressive hydration
   - start methylene blue 50mg q6hr for [**Doctor Last Name 8017**] neurotoxicity
   - f/u BMT recs
   .
   # Transaminitis: Patient has a mild transaminitis and elevated LDH
   likely due to chemo regimen and lysis of lymphoma cells.  MS changes
   unlikely due to hepatic encephalopathy but will check ammonia
   - continue to trend LFTs
   - f/u ammonia level
   .
   # FEN: NPO with LR at 100cc/hr
   - replete electrolytes prn
   .
   # PPx: pneumoboots, famotidine IV
   .
   # Comm: With patient and Son [**Name (NI) 225**] at [**Telephone/Fax (1) 8018**]
   - needs ICU consent
   .
   # Access: right upper chest port and PIV,
   - will get 2^nd PIV
   .
   # Code: FULL CODE (confirmed with patient)
   .
   # Dispo: pending above
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Indwelling Port (PortaCath) - [**2180-6-15**] 06:16 PM
   20 Gauge - [**2180-6-16**] 06:41 AM x2
   Prophylaxis:
   DVT:
   Stress ulcer: famotidine
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU for methylene blue treatment
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2180-6-15**] 11:15 AM
 URINE CULTURE - At [**2180-6-15**] 11:53 AM
 URINE CULTURE - At [**2180-6-15**] 02:00 PM
 NASAL SWAB - At [**2180-6-15**] 02:00 PM
 BLOOD CULTURED - At [**2180-6-15**] 02:10 PM
 EEG - At [**2180-6-15**] 05:50 PM
 INDWELLING PORT (PORTACATH) - START [**2180-6-15**] 06:16 PM
 MAGNETIC RESONANCE IMAGING - At [**2180-6-15**] 10:30 PM
 FEVER - 101.8
F - [**2180-6-15**] 12:00 PM
   ..
   -MRI: pending read
   -had n/v during MRI, ?aspiration, CXR: improved from AM
   -worsening nausea, KUB: nl, treated with zofran/compazine prn with
   effect
   -ABG all normal values
   -started methylene blue for [**Year (4 digits) **] toxicity
   -repleted K in AM
   Allergies:
   Demerol (Oral) (Meperidine Hcl)
   Nausea/Vomiting
   Last dose of Antibiotics:
   Vancomycin - [**2180-6-15**] 08:18 PM
   Piperacillin - [**2180-6-15**] 11:53 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2180-6-15**] 07:41 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2180-6-16**] 07:19 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.8
C (101.8
   Tcurrent: 36.7
C (98
   HR: 105 (82 - 125) bpm
   BP: 152/77(97) {105/56(71) - 169/88(165)} mmHg
   RR: 19 (8 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 73.6 kg (admission): 72.8 kg
             Total In:
                                                                  1,841 mL
                                                                    303 mL
   PO:
             TF:
   IVF:
                                                                  1,841 mL
                                                                    303 mL
   Blood products:
   Total out:
                                                                  2,480 mL
                                                                    910 mL
   Urine:
                                                                  2,180 mL
                                                                    860 mL
   NG:
                                                                    300 mL
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                   -639 mL
                                                                   -607 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula, 2L
   SpO2: 97%
   ABG: 7.38/35/91.[**Numeric Identifier 253**]/18/-3
   Physical Examination
   HEENT: PERRL, sclera anicteric, dry MM, oropharynx clear,
   CV: mildly tachy, normal S1 and S2, no m/r/g
   PULM: CTAB, no w/r appreciated
   ABD: +BS, soft, non-tender, non-distended with no palpable masses.
   LIMBS: cool, 2+ radial and DP pulses, no edema.
   SKIN: Dry skin on legs, no rashes.
   NEURO: oriented to person only, pupils reactive, moving all extremities
   and intermittently follows commands
   Labs / Radiology
   147 K/uL
   8.1 g/dL
   106 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.1 mEq/L
   24 mg/dL
   114 mEq/L
   142 mEq/L
   24.5 %
   6.2 K/uL
        [image002.jpg]
                             [**2180-6-15**]  11:41 AM
                             [**2180-6-15**]  07:47 PM
                             [**2180-6-16**]  03:56 AM
   WBC
   6.2
   Hct
   24.5
   Plt
   147
   Cr
   0.9
   TCO2
   19
   22
   Glucose
   106
   Other labs: PT / PTT / INR:12.3/24.2/1.0, ALT / AST:46/38, Alk Phos / T
   Bili:72/0.5, Lactic Acid:1.1 mmol/L, Ca++:7.5 mg/dL, Mg++:2.1 mg/dL,
   PO4:2.8 mg/dL
   .
   .
   BCx/Ucx pending
   .
   CXR: yesterday
   .
   MRI - pend
   Assessment and Plan
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 NAUSEA / VOMITING
   .
   Assessment and Plan
   74-year-old woman with recurrent follicular cell lymphoma who presented
   for induction with protocol Ofatumumab/ICE and was transferred to the
   ICU for acute mental status changes and fever.
   .
   # Acute MS changes: Etiology unclear, though concerning for [**Name (NI) 8017**]
   toxicity given recent completion of chemo regimen with known
   neurotoxicity. Infection also likely contributing with fever,
   tachycardia and tachypnea.  CXR with possible RLL infiltrate.  Hepatic
   encephalopathy unlikely given only mild elevation to LFTs. This is very
   unlikely to be meningitis acquired since admission to hospital, will
   hold off on LP for now and d/w neuro.
   - cont methylene blue and thiamine for [**Name (NI) 8017**] toxicity.
   - strict aspiration precautions
   - f/u neuro recs
   - cont empiric Vanc/Zosyn
   - f/u MRI
   - f/u blood & urine cx
   - f/u EEG
   .
   # ID: Pt with MS changes, witnessed emesis and likely aspiration
   event.  Currently tachypneic and febrile though oxygenating well, CXR
   concerning for RLL infiltrate although on f/u CXR today appears to be
   resolved. Pt just completed a course of chemo and WBC trending down.
   Pt is now hosp day 3 and will need to cover hosp acq organisms.
   Lactate normal on initial gas. Arrived in [**Hospital Unit Name 4**] yesterday with T 101.8,
   since then has been afebrile.
   - cont empiric Vanc/Zosyn for 48 hrs if neg cultures/afebrile
   - strict aspiration precautions
   - monitor resp status serially
   - ABGs/lactates prn
   .
   # Nausea: KUB nl, likely [**12-20**] to [**Month/Day (2) **] toxicity
   - zofran prn / compazine prn
   - if worsens will place NGT
   .
   # Non gap acidosis: likely secondary to NS fluid resuscitation
   - will continue to trend on AM lytes
   .
   # Follicular Cell Lymphoma: Pt with recurrent disease after initial
   treatment with RCHOP, she was admitted for induction with ICE+study
   [**Doctor Last Name **] in protocol regimen.  Pt was tolerating regimen well until today
   when she developped acute MS changes.  Now concern for [**Doctor Last Name 8017**]
   neurotoxicity, methylene blue indicated and safe at 6GPD levels NL.
   - chemo regimen complete, continue aggressive hydration
   - start methylene blue 50mg q6hr for [**Doctor Last Name 8017**] neurotoxicity
   - f/u BMT recs
   .
   # Transaminitis: Patient has a mild transaminitis and elevated LDH
   likely due to chemo regimen and lysis of lymphoma cells.  MS changes
   unlikely due to hepatic encephalopathy but will check ammonia
   - continue to trend LFTs
   - f/u ammonia level
   .
   # FEN: NPO with LR at 100cc/hr
   - replete electrolytes prn
   .
   # PPx: pneumoboots, famotidine IV
   .
   # Comm: With patient and Son [**Name (NI) 225**] at [**Telephone/Fax (1) 8018**]
   - needs ICU consent
   .
   # Access: right upper chest port and PIV,
   - will get 2^nd PIV
   .
   # Code: FULL CODE (confirmed with patient)
   .
   # Dispo: pending above
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Indwelling Port (PortaCath) - [**2180-6-15**] 06:16 PM
   20 Gauge - [**2180-6-16**] 06:41 AM x2
   Prophylaxis:
   DVT:
   Stress ulcer: famotidine
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU for methylene blue treatment<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 74-year-old woman with recurrent follicular cell lymphoma who was admitted to the ICU for acute mental status changes and fever. She had recently completed a chemotherapy regimen with known neurotoxicity and was transferred to the ICU for further management. The patient's mental status is altered, but not delirious, and she is experiencing nausea and vomiting. Her laboratory results show mild transaminitis and elevated LDH, likely due to the chemotherapy regimen. The patient is also experiencing a non-gap acidosis, likely secondary to NS fluid resuscitation.

Potential Medical Complications:

1. Methylene Blue Toxicity: The patient is receiving methylene blue for suspected [**Name (NI) 8017**] neurotoxicity, which may cause adverse effects such as methemoglobinemia, renal failure, or seizures.
2. Infection: The patient's fever, tachycardia, and tachypnea may indicate an underlying infection, which could worsen her condition if left untreated.
3. Aspiration Pneumonia: The patient's recent emesis and likely aspiration event increase her risk of developing aspiration pneumonia.
4. Hepatic Encephalopathy: Although the patient's liver function tests are mildly elevated, her mental status changes are unlikely due to hepatic encephalopathy. However, further monitoring of her liver function and ammonia levels is necessary.
5. Neurological Complications: The patient's altered mental status and potential [**Name (NI) 8017**] neurotoxicity increase her risk of developing neurological complications such as seizures, stroke, or cerebral edema.
6. Renal Complications: The patient's non-gap acidosis and potential methylene blue toxicity may increase her risk of developing renal failure or acute kidney injury.
7. Gastrointestinal Complications: The patient's nausea and vomiting may lead to dehydration, electrolyte imbalances, and gastrointestinal complications such as small bowel obstruction or perforation.

Based on this information, it is essential to closely monitor the patient's condition, manage her symptoms, and adjust her treatment plan as needed to prevent or mitigate these potential complications."
